Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
暂无分享,去创建一个
[1] A. IJzerman,et al. Inverse agonism at G protein‐coupled receptors: (patho)physiological relevance and implications for drug discovery , 2000, British journal of pharmacology.
[2] T. Schwartz,et al. Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor. , 2000, Molecular pharmacology.
[3] P. Kitabgi,et al. Identification of Residues Involved in Neurotensin Binding and Modeling of the Agonist Binding Site in Neurotensin Receptor 1* , 2000, The Journal of Biological Chemistry.
[4] A. Beaudet,et al. Pharmacological, molecular and functional characterization of glial neurotensin receptors , 1999, Neuroscience.
[5] J P Vincent,et al. Neurotensin and neurotensin receptors. , 1999, Trends in pharmacological sciences.
[6] J. Vincent,et al. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. , 1999, Molecular pharmacology.
[7] J. Costentin,et al. Identification of the Receptor Subtype Involved in the Analgesic Effect of Neurotensin , 1999, The Journal of Neuroscience.
[8] P Ferrara,et al. Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. , 1998, European journal of pharmacology.
[9] R. Leurs,et al. Agonist-independent regulation of constitutively active G-protein-coupled receptors. , 1998, Trends in biochemical sciences.
[10] M. Kaghad,et al. The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor* , 1998, The Journal of Biological Chemistry.
[11] P. Kitabgi,et al. Mutagenesis and Modeling of the Neurotensin Receptor NTR1 , 1998, The Journal of Biological Chemistry.
[12] P. Forgez,et al. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells. , 1998, Life sciences.
[13] W. Rostène,et al. Use of Nonpeptide Antagonists to Explore the Physiological Roles of Neurotensin , 1997, Annals of the New York Academy of Sciences.
[14] A. Beaudet,et al. Differential Binding Profile and Internalization Process of Neurotensin via Neuronal and Glial Receptors , 1997, The Journal of Neuroscience.
[15] E. Guillemare,et al. Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor , 1997, Neuroscience Letters.
[16] Philippe Sarret,et al. Structure, Functional Expression, and Cerebral Localization of the Levocabastine-Sensitive Neurotensin/Neuromedin N Receptor from Mouse Brain , 1996, The Journal of Neuroscience.
[17] P Ferrara,et al. Molecular cloning of a levocabastine‐sensitive neurotensin binding site , 1996, FEBS letters.
[18] M. Watson,et al. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. , 1994, Molecular pharmacology.
[19] P. Soubrié,et al. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes , 1994, British journal of pharmacology.
[20] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[21] P. Kitabgi,et al. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line. , 1993, The Biochemical journal.
[22] D. Craig,et al. The Cheng-Prusoff relationship: something lost in the translation. , 1993, Trends in pharmacological sciences.
[23] P Ferrara,et al. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor , 1993, FEBS letters.
[24] P. Kitabgi,et al. Reduced peptide bond pseudopeptide analogues of neurotensin: binding and biological activities, and in vitro metabolic stability. , 1991, European journal of pharmacology.
[25] W. Schütz,et al. Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding. , 1991, The Biochemical journal.
[26] Masayuki Masu,et al. Structure and functional expression of the cloned rat neurotensin receptor , 1990, Neuron.
[27] M. Caron,et al. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[28] A Herz,et al. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Rostène,et al. Different Subcellular Localization of Neurotensin‐Receptor and Neurotensin‐Acceptor Sites in the Rat Brain Dopaminergic System , 1988, Journal of neurochemistry.
[30] W. Rostène,et al. Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. , 1987, European journal of pharmacology.
[31] P. Laduron,et al. Different postnatal ontogeny of two [3H]neurotensin binding sites in rat brain , 1987, Brain Research.
[32] M. Caron,et al. The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system. , 1984, Biochemistry.
[33] P. Kitabgi,et al. Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors. , 1984, Biochemical and biophysical research communications.
[34] C. Granier,et al. Monoiodo-[Trp11]neurotensin, a highly radioactive ligand of neurotensin receptors. Preparation, biological activity, and binding properties to rat brain synaptic membranes. , 1983, The Journal of biological chemistry.
[35] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[36] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[37] G. Milligan,et al. Inverse agonism at adrenergic and opioid receptors: studies with wild type and constitutively active mutant receptors. , 1997, Receptors & channels.
[38] P. Soubrié,et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Kitabgi,et al. Reduced peptide bond pseudopeptide analogues of neurotensin. , 1992, Peptide research.